Pfizer seeks approval for omicron booster in kids over 5 years old
Published
Pfizer is seeking approval from the FDA for its updated COVID-19 booster shot targeting the omicron variant in kids between the ages of 5 and 11.
Full ArticlePublished
Pfizer is seeking approval from the FDA for its updated COVID-19 booster shot targeting the omicron variant in kids between the ages of 5 and 11.
Full ArticleWatch VideoPfizer asked U.S. regulators Monday to expand use of its updated COVID-19 booster shot to children ages 5 to..